BIOCIDE USAGE AND ANTIMICROBIAL RESISTANCE IN HOME SETTINGS: AN UPDATE A review by the International Scientific Forum on Home Hygiene (IFH) October 2003 The IFH Scientific Advisory Board Dr Rijkelt Beumer Laboratory of Food Microbiology, Department of Food Technology and Nutrition, Wageningen University Research Centre, Wageningen, The Netherlands Professor Sally F Bloomfield International Hygiene Research and Liaison Manager, Unilever Research, Port Sunlight, UK and Visiting Professor of Environmental Health, Division of Life Sciences, King’s College London, London, UK Professor Dr Martin Exner Director, Hygiene-Institut, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany Professor Gaetano M Fara Director, Istituto di Igiene "G. Sanarelli", Università "La Sapienza" di Roma, Rome, Italy Professor Kumar Jyoti Nath Director-Professor, Environmental Sanitation and Health. All India Institute of Hygiene and Public Health, Calcutta, India Dr Elizabeth Scott Consultant in Food and Environmental Hygiene, Newton, Massachusetts, USA BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE Biocide usage and antimicrobial resistance in home settings: an update Introduction A range of events over the past few years has raised awareness of the importance of the domestic setting in the chain of infection transmission through the community. Unfortunately however at a time when there is need to re-emphasise the importance of infection prevention through good hygiene, in the community as well as hospitals and other settings, a range of other issues related to infectious disease and its prevention have been publicised through the professional and lay press which, although they require serious consideration, have created a dilemma in the mind of the public. Whilst on one hand, publicity about emergent pathogens, antibiotic resistance, vaccination, food poisoning etc have increased concerns about how best to protect our family from infection, on the other we are now told that too little exposure to microbes could be weakening our immunity to infection and leaving us more exposed to allergic diseases (Rook and Stanford 1998). In addition, although it is generally agreed that the cause of antibiotic resistance in clinical practice is antibiotic overprescribing, some scientists suggest that widespread use of biocides, particularly in consumer products, may be a contributory factor (Levy 1998; Russell et al.1998, 1999a, Levy 2002). Most recently Aiello and Larson (2003) have hypothesised that the emergence of individuals in the community carrying antibiotic-resistant organisms in the absence of known risk factors might relate to the increasing use of antibacterial product (in particular those containing triclosan) in the community settings. Although IFH shares the concerns about the recent proliferation "antibacterial cleaners", our evaluation of the clinical and microbiological data suggests that there are times and places in the home, as in hospitals, where the use of a chemical disinfectant containing a biocidal agent is advisable. In giving this advice IFH was concerned as to whether there was any evidence to show that use of antimicrobials might be contributing to antibiotic resistance. In view of these concerns, IFH decided to undertake a review of the scientific data related to the possible links between antibiotic and biocide resistance. From this review, which was published in 2000 (http://www.ifh-homehygiene.org/public/micro00.htm)1, IFH concluded that, although some laboratory studies have demonstrated links between biocide and antibiotic resistance there is currently no evidence that it is a significant factor in the development of antibiotic resistance in clinical practice. It was agreed however that this aspect requires constant review. In this paper we re-evaluate these conclusions in the light of new data which has become available since the publication of our IFH review in 2002. This subject has also been recently reviewed by Gilbert and McBain (2003). Reduced susceptibility to biocides and antibiotic resistance 1 This paper was also published in German: Beumer, R., Bloomfield, S.F., Exner, M., Fara, G.M., Nath, K.J. and Scott, E. (2000) Resistenz von Mikroorganismen gegen Biozide. A review by the International Scientific Forum on Home Hygiene (IFH). Mhp-Verlag Wiesbaden, 2002. 2 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE When assessing the significance of antimicrobial resistance it is important to bear in mind that the term ‘resistance’ is a relative word. The microbicidal action of biocides (as opposed to antibiotics) results from their interaction with a number of distinct biochemical targets on or in the cell. Susceptibility of different microbes to an agent can vary significantly and changes in the most sensitive target can alter this sensitivity. The multiplicity of targets however usually dictates against the development of resistance (i.e treatment failure) because the concentrations used for hygiene applications are usually much higher than the minimum biocidal concentration. Similarly, although changes in permeability mediated either by envelope modification or by the expression of efflux pumps may reduce susceptibility, indications are that this has little influence on the outcome of biocide treatment at use concentrations. It has recently been proposed that long term exposure to biocides in commercially available hygiene products inevitable expose environmental microbial communities to sub-effective concentrations causing the emergence of resistant communities. Such resistance might related to mutational changes in the sensitive target site or to regulatory mutant which cause constitutive expression of efflux pumps. Although selection of communities with these modifications is unlikely to influence the susceptibility to biocides, changes in susceptibility to third party antibiotics can be postulated. This is particularly the case where the target site is shared between the antibiotic and the biocide, or where the induction of efflux is sufficient to confer clinical levels of antibiotic resistance. The significant number of studies investigating the relationship between resistance to biocides and antibiotics are reviewed in detail by McDonnell and Russell (1999), Beumer et al. (2000, http://www.ifh-homehygiene.org/public/micro00.htm) and Gilbert and Mc Bain (2003). Overall, these studies indicate no consistent pattern, the observations suggesting or refuting such a link varying according to the nature of the biocide and the antibiotic, the conditions under which the evaluation was carried out and the parameters assessed (MIC or bactericidal effects). In many cases, there is no indication of whether susceptibility changes were stable or reversible. In fact it would be unbelievable if links between biocide and antibiotic resistance were not observed since changes in the outer layers of the cell, particularly of Gram-negative species, are likely to affect resistance to both biocides and antibiotics. The variable response suggests that there is no single underlying cause. In the following sections, new data regarding the underlying mechanisms for which have been shown to be responsible for links between biocide and antibiotic resistance are reviewed. Biocide usage and antibiotic resistance. Where simultaneous changes in susceptibility to antibiotics, and to the types of biocides used as disinfectants and antiseptics, have been investigated, the resistance determinants mostly involved are genes encoding for multidrug efflux pumps – either plasmid-borne in Grampositive species or chromosomally-encoded in Gram-negatives. Links could also arise where a selective target site for biocides is shared by a therapeutic agent or agents. Since there are fundamental differences between these aspects they need to be considered separately. Chromosomally-encoded multidrug efflux pumps in Gram-negative bacteria Experimental evidence shows that chromosomally-encoded multidrug efflux pumps, such as the Mex pumps in Psedomonas aeruginosa and AcrAB in species such as Escherichia coli and Salmonella, are key in defining the intrinsic susceptibility of Gram-negative bacteria to both biocides and antibiotics, but also play a role in the development of multiresistance to 3 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE these agents. Upregulation of acrAB is largely but not exclusively controlled by the regulator MarA. Phenotypic adaptation in response to environmental stimuli, or mutations that increase expression of efflux genes or MarA result in elevated levels of resistance. Both antibiotic exposure and exposure to biocides has been shown to be a factor in the emergence of multidrug efflux mutants conferring reduced antibiotic susceptibility. Moken et al. (1997) showed that E. coli mutants selected for reduced susceptibility to pine oil disinfectant also show reduced susceptibility to multiple antibiotics including tetracycline, chloramphenicol, ampicillin and nalidixic acid, which is mediated via the mar and acr operons. Importantly, however, the level of antibiotic resistance which develops is relatively low and unlikely to compromise effectiveness in clinical use. In a recent study, Potenski et al. (2003) showed that mutants of Salmonella Enteritidis selected following exposure to the sanitizer chlorine, and food preservatives sodium nitrite, sodium benzoate and acetic acid showed reduced susceptibility to nalidixic acid, ciprofloxacin, tetracycline and chloramphenicol. Complementation experiments showed that mar mutation was responsible for this resistance. In general, the isolates exhibited a similar level of increased antibiotic resistance to each antibiotic. Although clinical resistance was not achieved (as was the case where the strain was exposed to tetracycline) the level of resistance was increase up to fourfold. These studies are similar to those reported by McMurry et al. (1998) who analysed 29 antibiotic resistant clinical E. coli isolates and found that 3 of these showed reduced susceptibility to triclosan of which 2 were mar mutants. It was not known if the antibiotic resistance was due to multidrug efflux, or whether the triclosan had selected for the antibiotic resistance, or the antibiotic resistance had selected for the triclosan resistance. In assessing the possible impact of biocide usage on efflux or mar-mediated antibiotic resistance it is important that it is considered in relation to other inimical agents which can elicit this effect. Miller and Sulavick (1996) review studies showing that MarRAB responds to a range of inducers reflecting a range of environmental conditions including the weak acid salicylate. Since tetracycline and chloramphenicol are less effective than salicylate (albeit at higher concentrations) in mar upregulation this suggests that salicylate is a ‘normal’ substrate for this pump. From their review, Miller and Sulavick (1996) suggest that the wide substrate specificity of these pumps and, for the AcrAB pump, regulation by global stress signals rather than specific substrates, make them well suited for a general defensive role. If efflux pumps evolved as a defence against antimicrobial agents occurring in the environment then it is to be expected that a wide range of ‘natural’ antimicrobial agents, including materials such as pine oils would produce these effects. In line with this Whyte et al. (2001) and Rickard et al (in press) have shown that a significant proportion of a wide range of food household and personal products acted as inducers of mar and acr when tested against lacz fusions of E. coli. This included food substances such as mustard, chilli and garlic, and household products, none of which made hygiene claims. The mar locus is widespread amongst bacterial species and has been shown to regulate up to 60 chromosomal genes. The marRAB regulon is induced by the positive regulator SoxS that is produced by transcription of soxRS in response to exposure to free radicals. It has been postulated (Dodd et al. 1998; Bloomfield et al.1998) that if bacterial cells are growth-arrested by treatment with an inimical agent, the imbalance between anabolism and catabolism causes a burst of free radical production. If this hypothesis is correct it is possible that any chemical 4 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE substance which produces a sudden decrease in growth rate including agents such as chlorine could cause increased expression of acr multidrug efflux pumps. Miller and Sulavick (1996) suggest that, although the wide substrate specificity of efflux pumps may make them well suited for a defensive role, it also means that cells may also pump out key metabolites making them relatively less competitive in mixed microbial communities. Thus it is likely (as suggested in recent studies by Gilbert to be discussed later in this paper) that, if the primary function is to facilitate continuous ‘modulation’ of efflux activity in response to their ever-changing environment, mutant populations which express efflux systems constitutively will decline in favour of wild type populations when the selective pressure is removed, although Levy (2000) suggests that this may not be the case. Plasmid-mediated efflux mechanisms in Gram-positive species Plasmid-mediated antibiotic resistance in Gram-positive bacteria is well established as a significant clinical problem. Since resistance to some biocides is also plasmid-mediated this raises concern that biocide exposure could contribute to spread of antibiotic resistance by selection and dispersal of plasmids producing resistance to both antibiotics and biocides. This could be a plasmid bearing a resistance determinant for a common target site shared by the antibiotic and one or more biocides or a biocide resistance determinant alongside structurally unrelated determinants for antibiotic resistance e.g., penicillin-binding proteins. For staphylococci, reduced biocide susceptibility is commonly associated with plasmidencoded efflux proteins. Studies of Staphylococcus aureus strains show that qacA, B, C and D genes encoding multidrug efflux in conjunction with antibiotic resistance determinants on multiresistance plasmids, are widely distributed in clinical and food isolates of Staph. aureus and are associated with reduced susceptibility (assessed by MICs) to biocides such as acriflavine, cetrimide, benzalkonium chloride (BAC) and chlorhexidine. Of concern is the finding that the qacA/B family of genes show significant homology to other energy-dependant transporters such as tetracycline transporters found in tetracycline-resistant strains, whilst qacA/B can be borne on penicillinase plasmids (Rouche et al. 1990; Russell et al. 1999a). In a recent study by Sidhu et al (2001) quaternary ammonium compound (QAC)-resistant coagulase negative staphlyococci isolated from food and food processing industries were investigated for the presence of genetic determinants (qacA/B and qacS/smr) encoding the resistance to the QAC, benzalkonium chloride and antibiotic resistance genes. Six qacA/Bharbouring strains were also found to harbour the B-lactamase gene blaZ. In three of these strains the gene were located on the same plasmid. Studies involving biocides with specific target sites As stated previously, many or most biocides attack several targets with differing susceptibilities depending on concentration. Although, under use conditions, bactericidal effects at higher concentrations may result from generalised cell disruption, growth inhibition at lower concentrations may occur through interaction with specific target sites. Where such sites are shared by a therapeutic agent then selection of a population bearing that target site by exposure to low level biocide, would have no effect on susceptibility to the biocide but could render the population clinically resistant to the therapeutic agent. Also of concern is the possibility (but no evidence) that, if the resistance determinants were transferred to plasmids also bearing determinants for one or unrelated targets conferring antibiotic resistance e.g., 5 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE penicillin binding proteins, then persistent low-level biocide exposure could select for antibiotic populations through selective pressure and plasmid transfer. Studies, as previously reviewed, showed that sublethal levels of triclosan select for mutants in the fabI gene of E. coli. FabI encodes the enoyl reductase enzyme, an essential enzyme involved in the synthesis of fatty acids. Triclosan shares this target with some therapeutic agents and as such could at sublethal concentrations select for resistance to third party antimicrobials. Reductions in the isoniazid sensitivity of Mycobacterium smegmatis can be conferred by mutation in inha which is a homologue of FabI. (McMurry et al. 1999). However similar phenomena have not been demonstrated for Mycobacterium tuberculosis which remains sensitive to triclosan (Parikh et al 2000, Slayden et al 2000). This suggests that although the 2 agents share the same target, their interactions with it are not the same. Other studies suggesting the possibility of shared target sites are described in our earlier IFH review of biocides and resistance. Biocide and antibiotic resistance in environmental and clinical settings Although the laboratory data suggests that some types of biocides do have the potential to encourage the emergence of antibiotic-resistance within microbial populations, either by selection of a multidrug resistant population or by transfer of multiresistant plasmids, the key question is whether and to what extent these mechanisms might operate in natural and clinical environments. In assessing the practical implications of the laboratory-based data, three criteria need to be assessed, firstly whether the level of antibiotic insusceptibility is sufficient to compromise the clinical response, secondly how extensively these mechanisms might occur in the environment or in clinical practice, and thirdly whether and to what extent theses resistant populations have the ability to compete and persist in the natural environment. Current evidence suggests that for Gram-negative multidrug efflux pumps, the level of antibiotic resistance induced or acquired through biocide exposure is relatively low and unlikely to compromise clinical effectiveness. The significance of multiresistant plasmid transfer in Gram-positive species, particularly in Staphylococcus species, still requires further investigation as does the possibility of mutation in shared target sites in Gram-negative and Gram-positive species. Although biocides are normally used at concentrations which are rapidly bactericidal, in any environment (or downstream of that environment) there is likely to be a continuum of biocide concentration ranging from treatment concentration to nil. Theoretically, sub-lethal concentrations of biocide for any given cellular target will occur at some point along this concentration gradient, providing a selection pressure for mutations in a multiplicity of cellular targets. Biofilm communities also provide highly selective environments where sharp gradients of antimicrobial agents will prevail and selective pressures will be greatest (Gilbert et al 2002). If acquisition of multi-target plasmids encoding reduced biocide susceptibility alongside antibiotic resistance is a real possibility, it is interesting to speculate to what extent this might occur outside the hospital environment. Logically the sequential addition of antibiotic resistance determinants onto plasmids conferring reduced susceptibility to biocides should only occur where bacterial populations are exposed to persistent low level of biocides and 6 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE also regularly subjected to the selective pressure from antibiotics. A number of studies have been recently reported which assess the prevalence of antibiotic resistant strains in community environments. Rutala et al. (2000) found that the frequency occurrence of antibiotic resistance in environmental isolates from homes was much lower than for clinical isolates from a hospital intensive care unit and an outpatient setting. A few isolates of Enterococcus and Enterobacter showed resistance to vancomycin and cefotaxime respectively, but no evidence of resistance was seen in isolates of Staph. aureus, Ps. aeruginosa, E.coli or Klebsiella pneumoniae. These results are in line with 2 further studies which investigated whether antibiotic resistant strains of bacteria were more likely to be found in domestic homes where antibacterial products were used compared with homes where they were not used (Marshall et al. 2003, Cole et al. 2003). Samples were collected from houses in the USA and UK of 30 users and nonusers of antibacterials. Susceptibility tests against antibiotics and antibacterial agents (triclosan, pine oil, BAC and para-chloro-meta-xylenol) were carried out on the bacteria isolated. The authors conclude that there was no evidence that antibiotic resistant strains occurred more frequently in user homes compared with non-user homes. An important aspect to consider is that, if the selection of mutants which are co-resistant to biocides and antibiotics through shared targets depends on the existence of specific biocide targets, it is unlikely (although not impossible) to apply to chemically-reactive agents such as chlorine or oxygen-releasing agents, or solvent molecules such as alcohols. This likelihood is further reduced by the fact that these agents are unstable or volatile and thus do not persist in the environment in an active form. A further aspect which has recently been investigated by Gilbert and co-workers is the “fitness” of resistant microbial clones resulting from exposure of naturally-occuring communities (which are inevitably mixed communities) to sublethal levels of biocides. Where a pathogen infects the body it has only to compete with host defences. In the general and domestic environment, bacteria have to survive in communities which are highly competitive, in which compromised strains will be rapidly replaced by more competent flora. To proliferate within a community of different species, a newly selected clone should demonstrate enhanced fitness. Many studies have show that development of antimicrobial resistance is associated with decreased fitness of the organism. Considering the prevalence of naturally resistant species, Gilbert has postulated that, rather than selection of resistant mutants, exposure to sublethal levels of biocides is more likely to cause clonal expansion or pre-existing resistant species. In this respect many biofilm communities are dominated by species which are refractory to a wide range of antimicrobial compounds. To investigate this possibility Gilbert and co-workers (McBain et al 2003a) have examined the effects of exposure of sink drain microcosms to triclosan. A long-term microcosm was stabilized for 6 months before being subjected to successive 3-month exposures to triclosan at sublethal concentrations. Culturable bacteria were identified and their susceptibilities to four biocides and six antibiotics were determined. Viable cell counts were largely unaffected by triclosan exposure, but species diversity was decreased. Triclosan susceptibilities ranged widely within bacterial groups, and triclosan-tolerant strains (including aeromonads, pseudomonads, stenotrophomonads, and Alcaligenes spp.) were isolated before and after triclosan exposure. Several triclosan-tolerant bacteria related to Achromobacter xylosoxidans became clonally expanded during dosing. Triclosan addition did not significantly affect the community profiles of susceptibility to the test biocides or antibiotics. It was also found that triclosan is degradable by common domestic biofilms. In a second study McBain et al (2003b) 7 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE investigated the effects of prolonged exposure of in vitro oral bacterial ecosystem within a constant-depth film fermenter to a chlorhexidine gluconate-containing mouthwash (CHXM). Results showed that CHXM exposure caused considerable decreases in microbial diversity. Pure-culture studies of 10 oral bacteria showed that Actinomyces naeslundii, Veillonella dispar, Prevotella nigrescens, and the streptococci were highly susceptible to CHX, while Lactobacillus rhamnosus, Fusobacterium nucleatum, and Neisseria subflava were the least susceptible. Determination of the MICs of triclosan, CHX, erythromycin, penicillin V, vancomycin, and metronidazole for microcosm isolates, before and after 5 days of CHXM exposure, showed that CHXM exposure altered the distribution of isolates toward those that were less susceptible to CHX. Changes in susceptibility distributions for the other test agents were not statistically significant. A similar pattern was observed for exposure of an in vitro plaque ecosystem exposed to a triclosan-containing mouthwash (McBain et al 2003c). These results are in line with earlier studies such as those of Armstrong et al. (1982) and Murray et al (1984) who reported that chlorination of sewage and of water supplies altered the distribution of isolates producing an increased proportion of species which showed reduced susceptibility to some (but not all) of a range of antibiotics which were tested. The concern must be as to whether the selective pressure from biocide exposure might select for species which are not only more resistant to antimicrobials, but also pathogenic. Gilbert and McBain (2002) conclude that the available data indicates that organisms such as environmental pseudomonads which are intrinsically resistant to all but the strongest oxidising biocides frequently benefit from biocidal treatments by clonal expansion into ecological niches previously occupied by more sensitive species, but in general these organisms are relatively benign. Murray et al, on the other hand expressed concern that some fo the species which they isolated from chlorinated sewage samples were potentially pathogenic. Also of concern, as reviewed by Aiello and Larson (2003), is the emergence of individuals in the community carrying antibiotic-resistant organisms in the absence of known risk factors. One of the observation which led Aiello and Larson to hypothesise that this might relate to the increasing use of antibacterial products in the community settings was that the observation that some community-acquired MRSA strains (c-MRSA) show an antibiotic susceptibility profile which is markedly different from hospital-acquired MRSA; cMRSA strains are chiefly resistant to B-lactams antibiotics (penicillins and cephalosporins). In line with this Akimitsu et al. (1999) showed that selection of MRSA with decreased susceptibility to BAC produced strains which were cross resistant to a variety of B-lactam antibiotics but not to other antibiotics. Levy (2001) noted that exclusive resistance to B-lactam antibiotics among MRSA isolates with decrease susceptibility to BAC matches the susceptibility of some c-MRSA isolates. This correlates with a report of 4 cases in different geographical, locations where children whose resistance was limited to lactam antibiotics died with MRSA (Anon 1999b). Aiello and Larson conclude however that much further research is necessary to examine these and other factors originating from the community setting that may have impact on antibiotic resistance. Conclusions The conclusion of the IFH (as also concluded by other reviewers (Russell et al. 1999a; Russell 2000; Gilbert and McBain 2003; Aiello and Larsen 2003) remains, namely that there is no equivocal evidence that biocide usage contributes to the development of antibiotic 8 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE resistance either in clinical practice or in the general environment; antibioitc use is currently assumed to be the major cause of antibiotic resistance in clinical practice. There is agreement however that, since significant questions remain unanswered however, it is vitally important that we continue to research and monitor the situation. Further, there is significant agreement that, as increases in antibiotic resistance continue to reduce our ability to treat infections, then infection prevention through hygiene, not only in hospitals but also in the community, becomes of even greater importance (Anon 1999a, 2000; Smith et al. 1999). Working parties across Europe and elsewhere engaged in implementing strategies to reduce antibiotic prescribing in humans also acknowledge the need for improved hygiene as a vital component of these strategies (Anon 1999a, 2000). The benefits of this approach have been demonstrated in clinical settings where good hygiene has contributed to reduced antibiotic resistance through reduced prescribing (Schmitz et al. 1998). Increasingly it is also recognised that good home hygiene also has a role on preventing the spread of antibiotic resistant strains which is increasingly seen as a community as well as a hospital problem (Aiello and Larsen 2003, Calfee et al 2003). Looking from this perspective, it is argued that if reducing the number of infections and the spread of resistant strains through effective hygiene is important, then it is also important to ensure that biocide use, as an integral part of good hygiene practice, is not discouraged in situations where there is real benefit in terms of preventing infection transmission. Overall there is strong evidence showing that good standards of hygiene can have a significant impact in reducing the number of infections arising in the home. It is also concluded that within a risk approach to home hygiene in situations where failure to achieve hygiene carries a risk of serious consequences (e.g. food hygiene), or in the protection of vulnerable groups, we should not be afraid to intervene with a disinfection process, either a heat process or an effective chemical disinfectant which will inactivate pathogens including bacteria and preferably also viruses. In making recommendations on the use of disinfectants in the home and other environments however it is important to distinguish between “general “ and “targeted” use. On the basis that concerns about antibiotic resistance remain unresolved the consensus view of IFH remains as before, which is that there is need to ensure that biocides are used responsibly i.e. in accordance with the recently published IFH “Recommendations for the selection of suitable hygiene procedures for use in the domestic environment” (Beumer et al. 2000, http://www.ifh-homehygiene.org/public/hypro00.htm). IFH also recommends that, in order to avoid the possibility of any impact on antimicrobial resistance in the future, reactive biocides (e.g. peroxide and hypochlorite bleach) and those which evaporate (alcohols) which disappear rapidly, leaving bacteria with no residue to which to develop tolerance should be preferred. REFERENCES Akimitsu, N., Hamamoto, H., Inoue, R., Shoji, M., Akamine, A., Takemori, K., Hamasaki, N. and Sekimisu, K. (1999) Increase in resistance of methicillin-resistant Staphylococcus aureus to -Lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrobial Agents and Chemotherapy, 43, 30423043. 9 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE Aiello, A.E. and Larson, E. (2003) Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. The Lancet infectious diseases, 3. 501-506. Anon (1999a) Official Journal of the European Communities C195, 1-3 Anon (1999b) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - Minnesota and North Dakota 1997-1999. Morbidity and Mortality Weekly Report 48, 707-710. Anon (2000) UK Antimicrobial Strategy Action Plan. Department of Health, London, UK. Armstrong, J. L., Calomiris, J. J. and Seidler, R.J. (1982) Selection of antibiotic resistant plate count bacteria during water treatment. Applied and Environmental Microbiology, 44, 308316. Bloomfield, S.F., Stewart, G.S.A.B., Dodd, C.E.R., Booth, I.R. and Power, E.G.M. (1998) The viable but non culturable phenomenon explained? Microbiology 144, 1-2. Calfee, D.P. Durbin, L.J. Germanson, T.P., Toney, D.M., Smith, E.B. and Farr, B.M. (2003) Spread of methicillin resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially-acquired MRSA. Infection Control and Epidemiology , 24, 422-426. Cole, E.C., Addison, R.A., Rubino, J.R., Leese, K.E., Dulaney, P.D., Newell, M.S., Wilkins, J., Gaber, D,J,. Weininger, T. and Criger, D.A. (2003) Investigation of antibiotic and antibacterial agent cross resistance in target bacteria from homes of antibacterial product users and non users. Journal of Applied Microbiology 95, 664-676 Dodd, C.E.R., Bloomfield, S.F., Booth, I.R. and Stewart, G.S.A.B. (1998) Suicide through stress: a cell’s response to sublethal injury. The Biochemist April, 12-14. Gilbert, P. Maira-Litran, T., McBain, A.J., Rickard, A.H. and Whyte, F. (2002) The physiology and collective recalcitrance of microbial biofilm communities. Advances in Microbial Physiology, 46, 203-256. Gilbert, P. and McBain, A. (2003) Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clinical Microbiological Reviews. 16, 189-208. Levy, S.B. (1998) The challenge of antibiotic reistance. Scientific American March, 322-39. Levy, S.B. (2000) Antibiotic and antiseptic resistance: impact on public health. Pediatric Infectious Disease Journal 19, S120-S122. Levy, S.B. (2001) Antibacterial household products: cause for concern. Emerging Infectious Diseases, 7, 512-515. Levy, S.B. (2002) Antibacterial household products: cause for concern. Emerging Infectious Diseases 7, (no 3 supplement), 512-515. Marshall, B.M., Roblet, E., Dumont, T., Billhimer, W., Wiandt, K., Keswick, B. , . Levy; S.B. (2003), The Frequency of Bacteria and Antibiotic Resistance in Homes that Use and do not Use Surface Antibacterial Agents. Abstracts of the Annual Meeting of the American Society for Microbiology. A-147 McBain, A.J, Bartelo, R.G., Catrenich, C. E., Charbonneau, D., Ledder, R.G., Price, B.B and Gilbert, P. (2003a) Exposure of sink drain microcosms to triclosan population dynamics and antimicrobial susceptibility. Applied and Environmental Microbiology 69, (in press) McBain, A.J, Bartelo, R.G., Catrenich, C. E., Charbonneau, D., Ledder, R.G., Price, B.B and Gilbert, P. (2003b) Effects of a chlorohexidine gluconate containing mouthwash on the vitality and antimicrobial susceptibility of an in vitro oral bacterial ecosystem. Applied and Environmental Microbiology 69, 4770-4776. 10 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE McBain, A.J, Bartelo, R.G., Catrenich, C. E., Charbonneau, D., Ledder, R.G., Price, B.B and Gilbert, P. (2003c) Effects of a triclosan-containing rinse on the dynamics and antimicrobial susceptibility of in vitro plaques ecosystems. Antimicrobial Agents and Chemotherapy, 47, 3531-3538. McDonnell, G. and Russell, A.D. (1999) Antiseptics and disinfectants: activity, action and resistance. Clinical Microbiology Reviews 12, 147-179. McMurry, L.M., Oethinger, M. and Levy, S.B. (1998) Overexpression of marA, soxS or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiology Letters 166, 305-309. McMurry, L.M., McDermott, P.F. and Levy, S.B. (1999) Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrobial Agents and Chemotherapy 43, 711-713. Miller, P.F. and Sulavick, M.C. (1996) Overlaps and parallels in the regulation of intrinsic multiple-antibiotic resistance in Escherichia coli. Molecular Microbiology 21, 441-448. Moken, M.C., McMurry, L.M. and Levy, S.B. (1997) Selection of multiple-antibioticresistant (Mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrobial Agents and Chemotherapy 41, 2770-2772. Murray, G.E., Tobin, R.S., Junkins, B. and Kushner, D.J. (1984) Effect of chlorination on antibiotic resistance profiles of sewage-related bacteria. Applied and Environmental Microbiology 48, 73-77. Parikh, S.L., Xiao, G., Tonge, P.J., (2000) Inhibition of InhA, the enoylreductase from Mycobacterium tuberculosis by triclosan and isoniazid. Biochemistry 30, 7645-7650.. Potenski, C.J., Ghandi, M. and Mathews, K.R. (2003) Exposure of Salmonella Enteritidis to chlorine or food preservatives increases susceptibility to antibiotics. FEMS Microbiology Letters, 220, 181-186. Rickard, A.H., Lindsay, S. and Gilbert, P. Indiction of mar operon by miscellaneous groceries (in press). Rook, G.A.W. and Stanford, J.L. (1998) Give us this day our daily germs. Immunology Today 19, 113-116 Rouche, D.A., Cram, D.S., DiBernadino, D., Littlejohn, T.G. and Skurray, R.A. (1990) Efflux-mediated antiseptic gene qacA from Staphylococcus aureus: common ancestry with tetracycline- and sugar-transport proteins. Molecular Microbiology 4, 2051-2062. Russell, A.D., Suller, M.T.E. and Maillard, J.Y. (1999a) Do antiseptics and disinfectants select for antibiotic resistance? Journal of Medical Microbiology 48, 613-615. Russell, A.D. and Maillard, J-Y. (2000) Response. American Journal of Infection Control 28, 204-206. Rutala, W.A., Weber, D.J., Barbee, S.I., Gergen, M.F. and Sobsey, M.D. (2000) Evaluation of antibiotic resistant bacteria in home kitchens and Bathrooms. Infection Control and Epidemiology 21, 132. Schmitz, F-J., Verhoef, H., Idel, H., Hadding, U., Heinz, H.P. and Jones, M.E. (1998) Impact of hygienic measures in the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital. Journal of Hospital Infection 38, 237-240. Sidhu, M.S. Heir, E., Sorum, H. andHolk, A. (2001) Genetic links between resistance to quaternary ammonium compounds and B-lactam antibiotics in food-related Staphylococcus species. Microbial Drug Resistance, 7, 363-371 Slayden, R.A., Lee, R.E., and Barry, C.E. (2000) Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis. Molecular Microbiology, 38, 524-528. 11 BIOCIDES USAGE AND MICROBIAL RESISTANCE UPDATE Smith, T.L., Pearson, M.L. and Wilcox, K.R. (1999) Emergence of vancomycin resistance in Staphylococcus aureus. New England Journal of Medicine 340, 493-501. Whyte, F.W., Allison, D.G., Jones, M.V and Gilbert, P. (2001) In vitro detection of multidrug antibiotic resistant (Mar) phenotype induction by miscellaneous groceries. Abstracts of the 104th Meeting of the American Society for Microbiology, A99. 12